TLR9-mediated signals rescue B-cells from Fas-induced apoptosis via inactivation of caspases

Immunology Letters

Volumn 143, Issue 1, 2012, Pages 77-84

  Hancz, Anikó ^a   Koncz, Gábor ^a   Szili, Dániel ^a   Sármay, Gabriella ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

Apoptosis; B cells; BAFF; Fas; TLR9

Indexed keywords

ABELSON KINASE; B LYMPHOCYTE RECEPTOR; CASPASE; CPG OLIGODEOXYNUCLEOTIDE; FAS ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAFFR; PROTEIN KINASE C; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTES; CASPASES; CELL LINE, TUMOR; ENZYME ACTIVATION; MICE; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9;

EID: 84858861935     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2012.02.006     Document Type: Article

References (63)

1. Melchers F., Rolink A., Grawunder U., Winkler T.H., Karasuyama H., Ghia P., et al. Positive and negative selection events during B lymphopoiesis. Curr Opin Immunol 1995, 7:214-227.
2. Fuentes-Panana E.M., Monroe J.G. Ligand-dependent and -independent processes in B-cell-receptor-mediated signaling. Springer Semin Immunopathol 2001, 23:333-350.
3. Fuentes-Panana E.M., Bannish G., Monroe J.G. Basal B-cell receptor signaling in B lymphocytes: mechanisms of regulation and role in positive selection, differentiation, and peripheral survival. Immunol Rev 2004, 197:26-40.
4. Liu Y.J., Arpin C. Germinal center development. Immunol Rev 1997, 156:111-126.
5. Liu Y.J., de Bouteiller O., Fugier-Vivier I. Mechanisms of selection and differentiation in germinal centers. Curr Opin Immunol 1997, 9:256-262.
6. Cancro M.P. Peripheral B-cell maturation: the intersection of selection and homeostasis. Immunol Rev 2004, 197:89-101.
7. Mizuno T., Zhong X., Rothstein T.L. Fas-induced apoptosis in B cells. Apoptosis 2003, 8:451-460.
8. Wang J., Watanabe T. Expression and function of Fas during differentiation and activation of B cells. Int Rev Immunol 1999, 18:367-379.
9. Lane P., Traunecker A., Hubele S., Inui S., Lanzavecchia A., Gray D. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol 1992, 22:2573-2578.
10. Mackay F., Browning J.L. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol 2002, 2:465-475.
11. Khan W.N. B cell receptor and BAFF receptor signaling regulation of B cell homeostasis. J Immunol 2009, 183:3561-3567.
12. Cancro M.P. Signalling crosstalk in B cells: managing worth and need. Nat Rev Immunol 2009, 9:657-661.
13. Kalled S.L. BAFF: a novel therapeutic target for autoimmunity. Curr Opin Investig Drugs 2002, 3:1005-1010.
14. Rathmell J.C., Cooke M.P., Ho W.Y., Grein J., Townsend S.E., Davis M.M., et al. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 1995, 376:181-184.
15. Rathmell J.C., Goodnow C.C. Autoimmunity The Fas track. Curr Biol 1995, 5:1218-1221.
16. Komano H., Ikegami Y., Yokoyama M., Suzuki R., Yonehara S., Yamasaki Y., et al. Severe impairment of B cell function in lpr/lpr mice expressing transgenic Fas selectively on B cells. Int Immunol 1999, 11:1035-1042.
17. Adachi M., Suematsu S., Suda T., Watanabe D., Fukuyama H., Ogasawara J., et al. Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc Natl Acad Sci U S A 1996, 93:2131-2136.
18. Rothstein T.L. Inducible resistance to Fas-mediated apoptosis in B cells. Cell Res 2000, 10:245-266.
19. Takahashi Y., Ohta H., Takemori T. Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire. Immunity 2001, 14:181-192.
20. Hao Z., Duncan G.S., Seagal J., Su Y.W., Hong C., Haight J., et al. Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis. Immunity 2008, 29:615-627.
21. Ait-Azzouzene D., Kono D.H., Gonzalez-Quintial R., McHeyzer-Williams L.J., Lim M., Wickramarachchi D., et al. Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus mice. J Immunol 2010, 185:1015-1027.
22. Acosta-Rodriguez E.V., Craxton A., Hendricks D.W., Merino M.C., Montes C.L., Clark E.A., et al. BAFF and LPS cooperate to induce B cells to become susceptible to CD95/Fas-mediated cell death. Eur J Immunol 2007, 37:990-1000.
23. Hancz A., Herincs Z., Neer Z., Sarmay G., Koncz G. Integration of signals mediated by B-cell receptor, B-cell activating factor of the tumor necrosis factor family (BAFF) and Fas (CD95). Immunol Lett 2008, 116:211-217.
24. Lamphier M.S., Sirois C.M., Verma A., Golenbock D.T., Latz E. TLR9 and the recognition of self and non-self nucleic acids. Ann N Y Acad Sci 2006, 1082:31-43.
25. Wang Z., Karras J.G., Colarusso T.P., Foote L.C., Rothstein T.L. Unmethylated CpG motifs protect murine B lymphocytes against Fas-mediated apoptosis. Cell Immunol 1997, 180:162-167.
26. Hartmann G., Krieg A.M. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol 2000, 164:944-953.
27. Bernasconi N.L., Onai N., Lanzavecchia A. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 2003, 101:4500-4504.
28. Capolunghi F., Cascioli S., Giorda E., Rosado M.M., Plebani A., Auriti C., et al. CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J Immunol 2008, 180:800-808.
29. Plebani A., Lougaris V., Soresina A., Meini A., Zunino F., Losi C.G., et al. A novel immunodeficiency characterized by the exclusive presence of transitional B cells unresponsive to CpG. Immunology 2007, 121:183-188.
30. Santiago-Raber M.L., Baudino L., Izui S. Emerging roles of TLR7 and TLR9 in murine SLE. J Autoimmun 2009, 33:231-238.
31. Chaturvedi A., Dorward D., Pierce S.K. The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. Immunity 2008, 28:799-809.
32. Carey G.B., Donjerkovic D., Mueller C.M., Liu S., Hinshaw J.A., Tonnetti L., et al. B-cell receptor and Fas-mediated signals for life and death. Immunol Rev 2000, 176:105-115.
33. Lanier L.L., Warner N.L., Ledbetter J.A., Herzenberg L.A. Quantitative immunofluorescent analysis of surface phenotypes of murine B cell lymphomas and plasmacytomas with monoclonal antibodies. J Immunol 1981, 127:1691-1697.
34. Bras A., Martinez A.C., Baixeras E. B cell receptor cross-linking prevents Fas-induced cell death by inactivating the IL-1 beta-converting enzyme protease and regulating Bcl-2/Bcl-x expression. J Immunol 1997, 159:3168-3177.
35. Hinshaw J.A., Mueller C.M., Scott D.W., Williams M.S. B cell receptor signaling mediates immediate protection from Fas-induced apoptosis upstream of caspase activation through an atypical protein kinase C isozyme and de novo protein synthesis. Eur J Immunol 2003, 33:2490-2500.
36. Moriyama H., Yonehara S. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes. Immunol Lett 2007, 109:36-46.
37. Foote L.C., Schneider T.J., Fischer G.M., Wang J.K., Rasmussen B., Campbell K.A., et al. Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cells. J Immunol 1996, 157:1878-1885.
38. de Alboran I.M., Robles M.S., Bras A., Baena E., Martinez A.C. Cell death during lymphocyte development and activation. Semin Immunol 2003, 15:125-133.
39. Peng S.L. Signaling in B cells via Toll-like receptors. Curr Opin Immunol 2005, 17:230-236.
40. Kurokawa M., Kornbluth S. Caspases and kinases in a death grip. Cell 2009, 138:838-854.
41. Raina D., Pandey P., Ahmad R., Bharti A., Ren J., Kharbanda S., et al. c-Abl tyrosine kinase regulates caspase-9 autocleavage in the apoptotic response to DNA damage. J Biol Chem 2005, 280:11147-11151.
42. Horita M., Andreu E.J., Benito A., Arbona C., Sanz C., Benet I., et al. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL. J Exp Med 2000, 191:977-984.
43. Smyth M.J. Imatinib mesylate--uncovering a fast track to adaptive immunity. N Engl J Med 2006, 354:2282-2284.
44. McGahon A.J., Nishioka W.K., Martin S.J., Mahboubi A., Cotter T.G., Green D.R. Regulation of the Fas apoptotic cell death pathway by Abl. J Biol Chem 1995, 270:22625-22631.
45. Alvarado-Kristensson M., Melander F., Leandersson K., Ronnstrand L., Wernstedt C., Andersson T. p38-MAPK signals survival by phosphorylation of caspase-8 and caspase-3 in human neutrophils. J Exp Med 2004, 199:449-458.
46. Cursi S., Rufini A., Stagni V., Condo I., Matafora V., Bachi A., et al. Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppression. Embo J 2006, 25:1895-1905.
47. Cohen P.L., Eisenberg R.A. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 1991, 9:243-269.
48. Wang J., Lobito A.A., Shen F., Hornung F., Winoto A., Lenardo M.J. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP. Eur J Immunol 2000, 30:155-163.
49. Schneider T.J., Fischer G.M., Donohoe T.J., Colarusso T.P., Rothstein T.L. A novel gene coding for a Fas apoptosis inhibitory molecule (FAIM) isolated from inducibly Fas-resistant B lymphocytes. J Exp Med 1999, 189:949-956.
50. Catlett I.M., Bishop G.A. Cutting edge: a novel mechanism for rescue of B cells from CD95/Fas-mediated apoptosis. J Immunol 1999, 163:2378-2381.
51. Gomez-Angelats M., Cidlowski J.A. Protein kinase C regulates FADD recruitment and death-inducing signaling complex formation in Fas/CD95-induced apoptosis. J Biol Chem 2001, 276:44944-44952.
52. Lim E.J., Park D.W., Lee J.G., Lee C.H., Bae Y.S., Hwang Y.C., et al. Toll-like receptor 9-mediated inhibition of apoptosis occurs through suppression of FoxO3a activity and induction of FLIP expression. Exp Mol Med 2010, 42:712-720.
53. Kuo C.C., Liang S.M., Liang C.M. CpG-B oligodeoxynucleotide promotes cell survival via up-regulation of Hsp70 to increase Bcl-xL and to decrease apoptosis-inducing factor translocation. J Biol Chem 2006, 281:38200-38207.
54. Janssens W., Carlier V., Wu B., VanderElst L., Jacquemin M.G., Saint-Remy J.M. CD4+CD25+ T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner. J Immunol 2003, 171:4604-4612.
55. Rothstein T.L., Wang J.K., Panka D.J., Foote L.C., Wang Z., Stanger B., et al. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995, 374:163-165.
56. Schattner E.J., Elkon K.B., Yoo D.H., Tumang J., Krammer P.H., Crow M.K., et al. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 1995, 182:1557-1565.
57. Nakanishi K., Matsui K., Kashiwamura S., Nishioka Y., Nomura J., Nishimura Y., et al. IL-4 and anti-CD40 protect against Fas-mediated B cell apoptosis and induce B cell growth and differentiation. Int Immunol 1996, 8:791-798.
58. Wurster A.L., Rodgers V.L., White M.F., Rothstein T.L., Grusby M.J. Interleukin-4-mediated protection of primary B cells from apoptosis through Stat6-dependent up-regulation of Bcl-xL. J Biol Chem 2002, 277:27169-27175.
59. Craxton A., Draves K.E., Gruppi A., Clark E.A. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway. J Exp Med 2005, 202:1363-1374.
60. Otipoby K.L., Sasaki Y., Schmidt-Supprian M., Patke A., Gareus R., Pasparakis M., et al. BAFF activates Akt and Erk through BAFF-R in an IKK1-dependent manner in primary mouse B cells. Proc Natl Acad Sci U S A 2008, 105:12435-12438.
61. Rickert R.C., Jellusova J., Miletic A.V. Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease. Immunol Rev 2011, 244:115-133.
62. Macfarlane D.E., Manzel L., Krieg A.M. Unmethylated CpG-containing oligodeoxynucleotides inhibit apoptosis in WEHI 231 B lymphocytes induced by several agents: evidence for blockade of apoptosis at a distal signalling step. Immunology 1997, 91:586-593.
63. Fraser C.K., Lousberg E.L., Kumar R., Hughes T.P., Diener K.R., Hayball J.D. Dasatinib inhibits the secretion of TNF-alpha following TLR stimulation in vitro and in vivo. Exp Hematol 2009, 37:1435-1444.